Coronavirus vaccine: who is leading the race?
As Sanofi and GSK secure the deal to supply up to 60 million potential vaccines to the UK government, we are looking at the pharma stocks involved in the race. IGTV’s Victoria Scholar is joined by IG’s Josh Warner, who talks us through some of the companies, including Pfizer, AstraZeneca, and Moderna. Josh explains why governments are eagerly buying stock in advance, and reminds that there are no vaccines from previous versions of coronavirus. The two discuss the opportunities for investors in the current uncertain environment. Follow us on Twitter @IGTV (https://twitter.com/IGTV) Fundamentals and charts: GlaxoSmithKline (GSK) (https://www.ig.com/uk/shares/markets-shares/glaxosmithkline-plc1-GSK-UK?CHID=9&SM=TW&REF=IGTV) Sanofi (https://www.ig.com/uk/shares/markets-shares/sanofi-aventis-SASY-FR?CHID=9&SM=TW&REF=IGTV) AstraZeneca (https://www.ig.com/uk/shares/markets-shares/astrazeneca-plc-AZN-UK?CHID=9&SM=TW&REF=IGTV) Moderna (https://www.ig.com/uk/shares/markets-shares/moderna-inc?CHID=9&SM=TW&REF=IGTV) Pfizer (https://www.ig.com/uk/shares/markets-shares/pfizer-inc-PFE-US?CHID=9&SM=TW&REF=IGTV) (All Sessions) BioTech (https://www.ig.com/uk/shares/markets-shares/biontech-se?CHID=9&SM=TW&REF=IGTV)